Diane E Griffin Selected Research

Diane E Griffin Research Topics

Disease

70	Infections 09/2023 - 01/2002
41	Measles 01/2023 - 01/2002
23	Encephalomyelitis (Myeloencephalitis) 09/2023 - 06/2003
16	Virus Diseases (Viral Diseases) 09/2023 - 02/2002
8	Alphavirus Infections 01/2021 - 11/2002
8	Exanthema (Rash) 01/2020 - 08/2005
7	Paralysis (Palsy) 09/2023 - 04/2004
5	COVID-19 10/2022 - 12/2020
5	Encephalitis (Encephalitis, Rasmussen) 01/2021 - 10/2002
4	Coinfection 01/2017 - 04/2002
4	Viremia 04/2014 - 08/2005
3	Central Nervous System Infections (Central Nervous System Infection) 05/2024 - 03/2006
3	Poliomyelitis (Polio) 06/2010 - 10/2006
2	Subacute Sclerosing Panencephalitis (SSPE) 01/2020 - 01/2018
2	Zika Virus Infection 01/2019 - 01/2017
2	Hemorrhage 03/2018 - 01/2018
2	Reinfection 01/2018 - 04/2014
2	Communicable Diseases (Infectious Diseases) 01/2018 - 01/2012
2	Rubella (German Measles) 04/2016 - 11/2007
2	Mumps 04/2016 - 11/2007
2	Hypersensitivity (Allergy) 07/2010 - 10/2002
2	HIV Infections (HIV Infection) 10/2009 - 09/2008
1	Melanoma (Melanoma, Malignant) 01/2023
1	Chikungunya Fever 12/2022
1	Arthritis (Polyarthritis) 01/2021
1	Necrosis 01/2019
1	Weight Loss (Weight Reduction) 01/2018
1	Neoplasms (Cancer) 01/2018
1	Congenital Abnormalities (Deformity) 01/2017

Drug/Important Bio-Agent (IBA)

32	VaccinesIBA 01/2023 - 04/2003
22	Proteins (Proteins, Gene)FDA Link 01/2023 - 02/2002
19	RNA (Ribonucleic Acid)IBA 05/2024 - 04/2002
16	Viral RNAIBA 01/2022 - 06/2003
12	Measles VaccineIBA 01/2018 - 01/2002
11	CytokinesIBA 09/2023 - 01/2002
11	Antiviral Agents (Antivirals)IBA 09/2023 - 01/2013
10	InterferonsIBA 10/2022 - 11/2002
9	AntibodiesIBA 01/2022 - 03/2003
8	Interleukin-10 (Interleukin 10)IBA 01/2022 - 10/2002
8	Interferon-gamma (Interferon, gamma)IBA 01/2020 - 10/2002
7	Hemagglutinins (Hemagglutinin)IBA 01/2020 - 09/2003
7	Neutralizing AntibodiesIBA 04/2016 - 11/2003
5	Immunoglobulin G (IgG)IBA 01/2022 - 11/2007
5	Immunoglobulin M (IgM)IBA 03/2018 - 08/2007
5	Glutamic Acid (Glutamate)FDA Link 10/2016 - 04/2004
5	Formaldehyde (Formol)FDA Link 04/2010 - 01/2002
4	HydrolasesIBA 12/2022 - 01/2018
4	AntigensIBA 01/2022 - 03/2003
4	Interleukin-12 (IL 12)IBA 01/2020 - 01/2002
4	Messenger RNA (mRNA)IBA 01/2019 - 01/2013
4	InterleukinsIBA 01/2017 - 10/2002
4	Glutamine (L-Glutamine)FDA Link 01/2017 - 04/2015
4	Interleukin-4 (Interleukin 4)IBA 01/2017 - 01/2002
3	Interleukin-6 (Interleukin 6)IBA 01/2023 - 01/2017
3	ChemokinesIBA 01/2020 - 10/2016
3	DiazooxonorleucineIBA 01/2017 - 04/2015
3	propionic acid (potassium propionate)IBA 01/2016 - 04/2004
2	Immunologic Factors (Immunomodulators)IBA 09/2023 - 01/2017
2	Interferon Regulatory FactorsIBA 09/2023 - 01/2019
2	Interleukin-18 (Interleukin 18)IBA 01/2023 - 01/2017
2	InflammasomesIBA 01/2023 - 10/2016
2	Complement System Proteins (Complement)IBA 01/2022 - 09/2003
2	Peptides (Polypeptides)IBA 01/2021 - 06/2007
2	EpitopesIBA 11/2019 - 06/2007
2	Measles-Mumps-Rubella Vaccine (MMR Vaccine)IBA 04/2016 - 06/2007
2	talampanelIBA 01/2016 - 03/2008
2	GYKI 52466IBA 01/2016 - 03/2008
2	Interferon LambdaIBA 04/2015 - 07/2013
2	LipidsIBA 10/2008 - 06/2002
2	AMPA Receptors (AMPA Receptor)IBA 03/2008 - 04/2004
2	alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA 03/2008 - 04/2004
2	Inactivated VaccinesIBA 01/2008 - 01/2002
2	Immunoglobulins (Immunoglobulin)IBA 06/2007 - 11/2003
1	Interferon Regulatory Factor-7 (Interferon Regulatory Factor 7)IBA 09/2023
1	NLR ProteinsIBA 01/2023
1	PyrinIBA 01/2023
1	Caspase 1 (ICE Protease)IBA 01/2023
1	phorbol-12-myristateIBA 01/2023
1	remdesivirIBA 01/2023
1	Adenosine Diphosphate Ribose (ADP-Ribose)IBA 12/2022
1	Small Interfering RNA (siRNA)IBA 10/2022
1	Poly AIBA 10/2022
1	Membrane Proteins (Integral Membrane Proteins)IBA 10/2022
1	Antiviral Restriction FactorsIBA 10/2022
1	DNA-Directed RNA Polymerases (RNA Polymerase)IBA 01/2022
1	Peptide Hydrolases (Proteases)FDA Link 01/2022
1	Transforming Growth Factor beta3 (TGF beta 3)IBA 01/2022
1	Peptide Initiation Factors (Initiation Factor)IBA 01/2021
1	Virulence Factors (Pathogenicity Factors)IBA 01/2021
1	Biological FactorsIBA 12/2019
1	Prokaryotic Initiation Factor-2IBA 12/2019
1	Combined VaccinesIBA 01/2018
1	Complementary DNA (cDNA)IBA 01/2018
1	ADP-ribosylarginine hydrolaseIBA 01/2018
1	Interleukin-2 (IL2)IBA 01/2017
1	E 10 (E-10)IBA 01/2017
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2017
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2017
1	Nucleocapsid ProteinsIBA 01/2017

Therapy/Procedure

4	Therapeutics 01/2022 - 01/2009